CEACAM5 and neoplasm: CEA.Tg mice bearing MC32A tumors and treated with the vaccine alone (Figure 2D) or combined with a lower dose of mGITRL-FP (0.1 mg/kg) (Figure 2E) resulted in no significant changes in MC32A tumor growth.